awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39101008-F85191FF-81C2-4B7F-A273-94B3FDC5C26A
Q39101008-F85191FF-81C2-4B7F-A273-94B3FDC5C26A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39101008-F85191FF-81C2-4B7F-A273-94B3FDC5C26A
Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.
P2860
Q39101008-F85191FF-81C2-4B7F-A273-94B3FDC5C26A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39101008-F85191FF-81C2-4B7F-A273-94B3FDC5C26A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a35f9e582b3297505afd1ad6bae5edf68388914
P2860
Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes.